# LL-37 oral COVID-19 trial: time to negative virus test

Source: https://pepvault.app/research/ll-37-zhao-2023

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [LL-37](https://pepvault.app/research#ll-37)

Randomized trial · people

# LL-37 taken by mouth shortened time to negative COVID-19 RNA test

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

This is a randomized human trial of an oral LL-37 product in which early treatment of hospitalized Omicron patients was linked to faster clearance of virus RNA without severe side effects.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 238
- **Published:** 2023
- **Journal:** J Med Virol

## What they tested

Researchers tested whether Oral LL-37, a recombinant Lactococcus lactis product taken by mouth, could speed clearance of an Omicron subvariant of SARS-CoV-2 and whether it was safe.

## How the study was done

An open-label, randomized, placebo-controlled trial at a single center in 238 adults hospitalized with COVID-19. Open-label means patients and doctors knew who got which treatment. The main outcomes were negative conversion time, how long until tests no longer found the virus's RNA, and side effects.

<!--promo-->

PepVault for iPhone

## Taking LL-37? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

When started by day 6 after the case was confirmed, Oral LL-37 shortened negative conversion time to 9.80 ± 2.67 versus 14.04 ± 5.89 with placebo (p < 0.01). Among people on Oral LL-37, starting within 6 days gave an adjusted hazard ratio for a negative test of 6.276 (95% CI 3.631-10.848) compared with starting later. Starting within 6 days also beat placebo, with a hazard ratio of 2.427 (95% CI 1.239-4.751). No severe side effects were seen during the hospital stay or follow-up.

## What it doesn’t show

Patients and staff knew who got which treatment, and the trial ran at a single hospital in inpatients with one Omicron subvariant. It measured how fast virus RNA cleared and safety, not other outcomes such as symptoms.

## The paper

Zhao et al. Efficacy and safety of Oral LL-37 against the Omicron BA.5.1.3 variant of SARS-COV-2: A randomized trial. J Med Virol. 2023.

- [PubMed (PMID 37605995)](https://pubmed.ncbi.nlm.nih.gov/37605995/)
- [The paper (DOI 10.1002/jmv.29035)](https://doi.org/10.1002/jmv.29035)

## The compound

- [LL-37: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/ll-37)
- [LL-37 dose guide](https://pepvault.app/lab/dosage/ll-37)

## With this study

### LL-37

- [LL-37: the full reference](https://pepvault.app/peptides/ll-37)
- [LL-37 dose guide](https://pepvault.app/lab/dosage/ll-37)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/ll-37-5mg)

### Studies

- [LL-37 cream: bigger granulation gains in diabetic foot ulcers](https://pepvault.app/research/ll-37-miranda-2023)
- [LL-37: no healing gain over placebo for venous leg ulcers overall](https://pepvault.app/research/ll-37-heal-ll-37-2021)
- [All 6 studies](https://pepvault.app/research#ll-37)

### Compared with

- [KPV vs LL-37](https://pepvault.app/peptides/compare/kpv-vs-ll-37)
- [Thymosin Alpha-1 vs LL-37](https://pepvault.app/peptides/compare/thymosin-alpha-1-vs-ll-37)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Open-label](https://pepvault.app/glossary/open-label)

## More studies on LL-37

- [LL-37 cream: bigger granulation gains in diabetic foot ulcers](https://pepvault.app/research/ll-37-miranda-2023) Randomized trial · people · 2023
- [LL-37: no healing gain over placebo for venous leg ulcers overall](https://pepvault.app/research/ll-37-heal-ll-37-2021) Randomized trial · people · 2021
- [LL-37 blood levels highest in adults with lung tuberculosis](https://pepvault.app/research/ll-37-majewski-2017) Observational study · people · 2017
- [LL-37 drove IL-1β and IL-18 release from human and murine macrophages](https://pepvault.app/research/ll-37-kahlenberg-2013) Cell study · human and murine macrophages · 2013
- [LL-37 raised TLR9 and interferon output in human skin cells](https://pepvault.app/research/ll-37-morizane-2012) Cell study · normal human keratinocytes · 2012
- [Every study on LL-37](https://pepvault.app/research#ll-37)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking LL-37? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking LL-37? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### LL-37

- [LL-37: the full reference](https://pepvault.app/peptides/ll-37)
- [LL-37 dose guide](https://pepvault.app/lab/dosage/ll-37)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/ll-37-5mg)

### Studies

- [LL-37 cream: bigger granulation gains in diabetic foot ulcers](https://pepvault.app/research/ll-37-miranda-2023)
- [LL-37: no healing gain over placebo for venous leg ulcers overall](https://pepvault.app/research/ll-37-heal-ll-37-2021)
- [All 6 studies](https://pepvault.app/research#ll-37)

### Compared with

- [KPV vs LL-37](https://pepvault.app/peptides/compare/kpv-vs-ll-37)
- [Thymosin Alpha-1 vs LL-37](https://pepvault.app/peptides/compare/thymosin-alpha-1-vs-ll-37)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Open-label](https://pepvault.app/glossary/open-label)

<!--promo-->

PepVault for iPhone

## Taking LL-37? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on LL-37](https://pepvault.app/research#ll-37)

## The library

- [LL-37](https://pepvault.app/peptides/ll-37)
- [LL-37 dose guide](https://pepvault.app/lab/dosage/ll-37)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
